glutathione phase i Detoxification: and Phase II Detox Genes Mobile Phase

10.1158/2159-8290.CD-20-1453 86 TangD.ChenX.KangR.KroemerG

identified CDC as an ALOX5-specific antagonist with an IC 50 value in the low nanomolar range (925 nM) measured in cell-free assays

Peters 1,2 , Erica DePasquale 1 , Gousia Begum 1 , Krishna Roskin 1,2 , E

Some scholars have used the synoviocyte mitochondrial gene encoding NADH dehydrogenase 1 as an entry point in order to study the mutation level of synoviocyte mtDNA in rheumatoid arthritis, and have found that the number of mutations in RA synoviocyte mtDNA is approximately twice as high as that of the OA group, and that RA fibroblasts are expressed at a mutation load of 2.3 amino acid changes per thousand base pairs, whereas in tissues, there are 2.3 changes per 2.5 amino acid changes per thousand base pairs

Use of glutathione reduces kidney toxicity for Intravenous (IV) chelation therapies